Logo image of DCBO

DOCEBO INC (DCBO) Stock Fundamental Analysis

NASDAQ:DCBO - Nasdaq - CA25609L1058 - Common Stock - Currency: USD

32.06  -1.1 (-3.32%)

Fundamental Rating

6

DCBO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. Both the profitability and the financial health of DCBO get a neutral evaluation. Nothing too spectacular is happening here. DCBO is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make DCBO a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

DCBO had positive earnings in the past year.
In the past year DCBO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO has a Return On Assets of 14.02%. This is amongst the best in the industry. DCBO outperforms 90.11% of its industry peers.
Looking at the Return On Equity, with a value of 46.29%, DCBO belongs to the top of the industry, outperforming 95.41% of the companies in the same industry.
DCBO has a Return On Invested Capital of 17.84%. This is amongst the best in the industry. DCBO outperforms 93.99% of its industry peers.
Industry RankSector Rank
ROA 14.02%
ROE 46.29%
ROIC 17.84%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

DCBO has a Profit Margin of 12.32%. This is in the better half of the industry: DCBO outperforms 78.45% of its industry peers.
The Operating Margin of DCBO (8.72%) is better than 75.62% of its industry peers.
DCBO has a better Gross Margin (80.96%) than 84.10% of its industry peers.
In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 8.72%
PM (TTM) 12.32%
GM 80.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DCBO is creating some value.
The number of shares outstanding for DCBO remains at a similar level compared to 1 year ago.
DCBO has more shares outstanding than it did 5 years ago.
DCBO has a better debt/assets ratio than last year.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

DCBO has an Altman-Z score of 4.65. This indicates that DCBO is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.65, DCBO is doing good in the industry, outperforming 65.37% of the companies in the same industry.
The Debt to FCF ratio of DCBO is 0.05, which is an excellent value as it means it would take DCBO, only 0.05 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DCBO (0.05) is better than 79.86% of its industry peers.
DCBO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
DCBO has a better Debt to Equity ratio (0.00) than 66.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 4.65
ROIC/WACC1.39
WACC12.88%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.20 indicates that DCBO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.20, DCBO is doing worse than 65.02% of the companies in the same industry.
A Quick Ratio of 1.20 indicates that DCBO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.20, DCBO is doing worse than 65.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 744.44% over the past year.
Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 19.96% in the last year.
Measured over the past years, DCBO shows a very strong growth in Revenue. The Revenue has been growing by 39.25% on average per year.
EPS 1Y (TTM)744.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180%
Revenue 1Y (TTM)19.96%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%15.75%

3.2 Future

Based on estimates for the next years, DCBO will show a very strong growth in Earnings Per Share. The EPS will grow by 30.96% on average per year.
Based on estimates for the next years, DCBO will show a very strong growth in Revenue. The Revenue will grow by 24.94% on average per year.
EPS Next Y36.36%
EPS Next 2Y36.85%
EPS Next 3Y26.83%
EPS Next 5Y30.96%
Revenue Next Year12.1%
Revenue Next 2Y13.31%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

DCBO is valuated quite expensively with a Price/Earnings ratio of 42.18.
62.19% of the companies in the same industry are more expensive than DCBO, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.71, DCBO is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 30.94, the valuation of DCBO can be described as expensive.
DCBO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 66.08% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.34, DCBO is valued a bit more expensive.
Industry RankSector Rank
PE 42.18
Fwd PE 30.94
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DCBO is valued a bit cheaper than 69.96% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 71.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 34.67
EV/EBITDA 40.96
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

DCBO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of DCBO may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 26.83% in the coming years.
PEG (NY)1.16
PEG (5Y)N/A
EPS Next 2Y36.85%
EPS Next 3Y26.83%

More info and screens

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOCEBO INC

NASDAQ:DCBO (3/6/2025, 1:42:28 PM)

32.06

-1.1 (-3.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-28 2025-02-28/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners35.68%
Inst Owner Change-4.58%
Ins Owners1.39%
Ins Owner ChangeN/A
Market Cap970.78M
Analysts80
Price Target36.93 (15.19%)
Short Float %0.4%
Short Ratio0.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)24.96%
Min EPS beat(2)-25.3%
Max EPS beat(2)75.22%
EPS beat(4)3
Avg EPS beat(4)20.11%
Min EPS beat(4)-25.3%
Max EPS beat(4)75.22%
EPS beat(8)6
Avg EPS beat(8)0.34%
EPS beat(12)9
Avg EPS beat(12)123.22%
EPS beat(16)11
Avg EPS beat(16)77.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)0.37%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-1.42%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.74%
Revenue beat(12)1
Avg Revenue beat(12)-1.13%
Revenue beat(16)4
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)-5.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.53%
EPS NY rev (1m)0%
EPS NY rev (3m)13.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 42.18
Fwd PE 30.94
P/S 4.48
P/FCF 34.67
P/OCF 33.19
P/B 16.81
P/tB 22.98
EV/EBITDA 40.96
EPS(TTM)0.76
EY2.37%
EPS(NY)1.04
Fwd EY3.23%
FCF(TTM)0.92
FCFY2.88%
OCF(TTM)0.97
OCFY3.01%
SpS7.16
BVpS1.91
TBVpS1.39
PEG (NY)1.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.02%
ROE 46.29%
ROCE 30.44%
ROIC 17.84%
ROICexc N/A
ROICexgc N/A
OM 8.72%
PM (TTM) 12.32%
GM 80.96%
FCFM 12.91%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score7
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 36.79%
Cap/Sales 0.57%
Interest Coverage 250
Cash Conversion 131.21%
Profit Quality 104.74%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 4.65
F-Score7
WACC12.88%
ROIC/WACC1.39
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)744.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180%
EPS Next Y36.36%
EPS Next 2Y36.85%
EPS Next 3Y26.83%
EPS Next 5Y30.96%
Revenue 1Y (TTM)19.96%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%15.75%
Revenue Next Year12.1%
Revenue Next 2Y13.31%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%
EBIT growth 1Y2680.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.6%
EBIT Next 3Y58.04%
EBIT Next 5Y43.83%
FCF growth 1Y82.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.22%
OCF growth 3YN/A
OCF growth 5YN/A